secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acurx Pharmaceuticals, Inc. (ACXP)
CIK:        0001736243
Form:       8-K
Filed at:   2025-09-19T23:59:59+00:00
Accession:  0001104659-25-091733
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Acurx shareholders approve warrant exercise and authorized share increase at special meeting
--------------------------------------------------------------------------------

- Proposal 1 (warrant exercise for Nasdaq compliance): 8,816,581 for, 602,155 against, 9,823,429 broker non-votes.
- Proposal 2 (authorized share increase 200M to 250M): 16,476,460 for, 2,526,119 against, 363,000 abstentions.
- Proposal 3 (adjournment) approved: 16,538,163 for, 2,271,234 against, 556,182 abstentions.
- Quorum: 19,365,579 shares (63.44%) of 30,524,540 outstanding shares represented.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1736243/000110465925091733/0001104659-25-091733-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1736243/000110465925091733/tm2526531d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-091733

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer